Menu
Back to Journals » Clinical Ophthalmology » Volume 3
Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube
Authors Tsui I, Airiani S, Wen A, El-Sawy T, Fine HF, Maris Jr PJ
Published 10 September 2008 Volume 2009:3 Pages 91—93
DOI https://doi.org/10.2147/OPTH.S3831
Review by Single anonymous peer review
Peer reviewer comments 1
Irena Tsui, Suzanna Airiani, Angie Wen, Tarek El-Sawy, Howard F Fine, Peter JG Maris Jr
Department of Ophthalmology, Columbia University, New York, NY, USA
Abstract: Implanting glaucoma tubes through the pars plana in the setting of a corneal transplant is becoming more common, and there are unique problems associated with such a procedure. A 42-year-old man with multiple previous eye surgeries presented with a nonfunctioning pars plana glaucoma tube. There was no view to the tube tip, but it was presumed to be clogged with fibrin. Intravitreal tissue plasminogen activator (tPA) was injected through the pars plana which resulted in intraocular pressure control without further surgery. This new application of intravitreal tPA has not been reported previously. Future research should investigate the optimal effective and safe dose of intravitreal tPA injection to relieve such occlusions.
Keywords: tissue plasminogen activator (tPA), Ahmed Glaucoma Valve
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.